Eli Lilly CFO leaves after "exhibiting poor judgment"
Josh Smiley, CFO at Eli Lilly, leaves the company after a having "exhibited poor judgment" in a relationship to a colleague, according to the US pharmaceutical giant in a Tuesday announcement. His replacement has been instated.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Eli Lilly's Chief Financial Officer Josh Smiley steps down from Eli Lilly following accusations of an inappropriate relationship between him and an employee, according to a Tuesday press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly skyrockets following positive Alzheimer's data
For subscribers
.jpg&w=384&q=75)
